Home Trial Support in Oncology Clinical Trials

This case study examines the implementation of Home Trial Support (HTS) in oncology clinical trials, focusing on its impact on patient enrollment and retention. HTS allows patients to participate in trials from their homes, reducing the need for frequent travel to clinical sites. This approach enhances accessibility for patients with mobility issues and alleviates the burdens associated with traditional trial participation. The study highlights that enrollment was completed in 11 months, which was one month ahead of the target, and recruitment was 40% faster compared to traditional methods. The case study also details the types of cancer trials supported, including solid tumors and leukemia, and emphasizes the importance of patient-centric care in clinical research. It discusses the various in-home activities conducted during trial visits, such as toxicity scoring and IV infusion, and underscores the significance of building trust between patients and healthcare professionals. Overall, HTS represents a flexible solution tailored to meet the needs of oncology patients.